Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Alejandra Bravo is a pioneering robotic surgeon whose work is reshaping the landscape of minimally invasive urologic oncology and transplantation. Her primary research focuses on the clinical implementation and optimization of next-generation robotic platforms, particularly the Hugo™ Robot-Assisted Surgery (RAS) system, for complex pelvic and renal procedures. Dr. Bravo’s major contributions include demonstrating the feasibility and safety of the Hugo™ system for robot-assisted radical prostatectomy (RARP) and radical cystectomy (RARC), as detailed in her 2023 study (20 citations). She has also advanced the field by performing retroperitoneal robot-assisted partial nephrectomy using this novel platform, showcasing its versatility. Furthermore, her work on robotic kidney transplantation (2024, 27 citations) represents a significant step toward expanding the applications of robotic surgery in transplantation. By systematically reporting surgical settings and preliminary outcomes, Dr. Bravo is providing the foundational evidence needed for the broader adoption of these technologies. Her research is critical for surgeons seeking to integrate new robotic systems into practice, and her findings are directly shaping the future of precision surgery in urology and beyond.